Liz Higgins - Haematology Association of Ireland

More documents

Recommendations

Info

Storage Liquid Nitrogen Stored in Vapour phase - 190 C 15 Years
PBSC Mobilisation Initial Review FBC RLB Pr<strong>of</strong>ile Coagulation Blood group G&H Disease markers Virology – Hepatitis B,C; HIV 1&2; HTLV 1&2; Syphilis Consider venous access – peripheral/central Medical assessment Nursing Assessment Counselling CXR/ ECG/ ECHO Consent Correspondence
Page 1 and 2: AutologousPeripheral Blood Stem Cel
Page 3 and 4: PBSCH 2008 71 2009 75 2010 54 to da
Page 5 and 6: PBSCT PBSCT involves eliminating an
Page 7 and 8: Cancers treated by Autologous PBSCT
Page 9 and 10: Sources of Bone Marrow Stem Cells B
Page 11: PBSCH COMMISSION DIRECTIVE 2006/17/
Page 15 and 16: Cyclophosphamide 2g/m 2 Chemo on Mo
Page 17 and 18: ICE Etoposide 10mg/m 2 Day 1,2,3.,
Page 19 and 20: Eshap Commence Tuesday Day 12-14
Page 22 and 23: Apheresis guidelines
Page 24: COBE
Page 27 and 28: Autologous HSCT in multiple myeloma
Page 29 and 30: Indication Plerixafor is indicated
Page 31 and 32: Mechanism of action of Plerixafor P
Page 33 and 34: Plerixafor increases predictability

Liz Higgins - Haematology Association of Ireland

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?